ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.

Saved in:
Bibliographic Details
Main Authors IWAMOTO, Mitsuhiro, OTA, Yusuke, HAYAKAWA, Ichiro, TERAUCHI, Tomoko, OKAJIMA, Daisuke, DOI, Fuminao, UCHIDA, Hiroaki, HAMADA, Hirofumi, MEGURO, Masaki, ASHIDA, Shinji, MASUDA, Takeshi, TODA, Narihiro, NAKADA, Takashi, NAKAMURA, Kensuke, HARADA, Naoya
Format Patent
LanguageEnglish
Published 15.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
Bibliography:Application Number: US202217849688